Hosted By
Senate Democrats are poised to pass a reconciliation bill next week that would, among other things, allow the federal government to "negotiate" prescription drug prices and more.
Sally C. Pipes, president and CEO of the Pacific Research Institute, spoke on the bill's impact and how it will affect inflation and the future of drug development. Sally has recently published op-eds on how the reconciliation package will undermine drug research in the likes of the Washington Examiner, Newsmax, and the Pittsburgh Post-Gazette. Find her article here.
HR 1 Rush To Reason September 23 2020 by John Rush
Richard Battle, "After hearing one too many commencement speeches long on words but short on inspiration, I want to offer my address to graduates...
If a Jewish Congressman will not do anything to stop the rise of anti-Semitic ones, then who will?Jeffery Berk of Truth Tells joins John...
